AI-generated summary
The authors report a multicenter observational study of 268 patients with musculoskeletal disorders who received combined TECAR and low-level laser therapy. They describe a statistically significant, progressive reduction in pain scores across four time points. Because the design was observational and cross-sectional without a control group, and the authors call for randomized trials, the findings cannot establish that the combined treatment caused the pain reduction.
- Participants
- 268
- Who or what was studied
- Patients with clinically and imaging-confirmed musculoskeletal disorders, including knee osteoarthritis, lumbar and cervical disc herniation, spondylosis and tendinopathies
- Limits stated in the abstract
- The study was observational and cross-sectional without a control group, and the authors state that randomized studies with functional assessments and long-term follow-up are still required.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Introduction Musculoskeletal disorders represent a major global burden, being the main cause of global disability. Current management of musculoskeletal pain includes medication (non-steroidal anti-inflammatory drugs, opioids, intra-articular injections), physiotherapy, and surgery. A modern approach in musculoskeletal pain physiotherapy is capacitive and resistive energy transfer (TECAR) therapy associated with low-level laser therapy (LLLT). Materials and methods We conducted a prospective, observational, cross-sectional, multicenter clinical study that included a total of 268 patients with clinically and imaging-confirmed musculoskeletal disorders. The collected data were entered and processed using IBM SPSS Statistics for Windows, Version 20 (Released 2011; IBM Corp., Armonk, New York, United States). Results The repeated-measures ANOVA revealed a statistically significant and progressive reduction in visual analog scale (VAS) scores across the four time points, demonstrating that the combined TECAR and LASER therapy produced a consistent and clinically relevant improvement in pain. The benefits have been observed across multiple pathologies, including knee osteoarthritis, lumbar and cervical disc herniation, spondylosis, and tendinopathies, with consistent clinical responses across subgroups. Conclusion TECAR combined with LLLT represents a non-invasive, effective, and well-tolerated intervention, with the potential to become a central component in the management of chronic musculoskeletal pain. However, further randomized, multicenter studies incorporating functional assessments and long-term follow-up are required to confirm and extend these findings.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Visual analogue scale, Osteoarthritis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.